Indication
Chronic Kidney Disease Stage 3
2 clinical trials
4 products
Clinical trial
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D InsufficiencyStatus: Completed, Estimated PCD: 2020-04-24
Product
CalcifediolProduct
CholecalciferolProduct
ParicalcitolClinical trial
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease - Randomized, Double-blind, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-31
Product
Sulforaphane